{"transactions":[{"id":3273797,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-02-13T21:14:56.000Z","date":"2020-02-11","kind":"tax_withholding","acquired":false,"shares":5613,"price":1.71,"value":9598.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":127769,"source":{"system":"sec-edgar","filing":"0001209191-20-009164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120009164/doc4.xml","form_type":"4"}},{"id":3284376,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-08T02:08:06.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the grant date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":1.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-007738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120007738/doc4.xml","form_type":"4"}},{"id":3284375,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-02-08T02:08:06.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units shall vest in three equal consecutive annual installments on February 6, 2021, February 6, 2022 and February 6, 2023."}],"balance_after":133382,"source":{"system":"sec-edgar","filing":"0001209191-20-007738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120007738/doc4.xml","form_type":"4"}},{"id":3381976,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-04T11:05:19.000Z","date":"2019-11-02","kind":"grant","acquired":true,"shares":26125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2018, the reporting person was granted a performance-based option to purchase 52,250 shares of common stock, subject to the Company's achievement of commercial approval by the U.S. Food and Drug Administration (\"FDA\") of its new drug application for \"DSUVIA\" on or before February 15, 2019. Once the performance criteria is achieved, the option vests in two equal installments with 50% of the option vesting upon the Company's achievement of the performance criteria and the remaining 50% of the option vesting on the one-year anniversary of the date of such achievement, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 26,125 shares on that date. On November 2, 2019, the remaining balance of the option vested."}],"balance_after":52250,"derivative":{"exercise_price":2.225,"exercise_date":"2019-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":26125},"source":{"system":"sec-edgar","filing":"0000899243-19-026513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000089924319026513/doc4.xml","form_type":"4"}},{"id":3618758,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-03-04T21:24:31.000Z","date":"2019-02-28","kind":"purchase","acquired":true,"shares":3682,"price":2.81,"value":10346.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance includes non-reportable acquisition of 3,682 shares of Common Stock through the Company's Employee Stock Purchase Plan."}],"balance_after":78053,"source":{"system":"sec-edgar","filing":"0001209191-19-015617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919119015617/doc4.xml","form_type":"4"}},{"id":3660233,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T22:45:21.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":2.51,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-009822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919119009822/doc4.xml","form_type":"4"}},{"id":3660232,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-02-13T22:45:21.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2020, February 11, 2021 and February 11, 2022."}],"balance_after":74371,"source":{"system":"sec-edgar","filing":"0001209191-19-009822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919119009822/doc4.xml","form_type":"4"}},{"id":3774059,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T22:29:07.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2018, the reporting person was granted an option to purchase 52,250 shares of common stock. The option vests in two equal annual installments based on  Company's achievement of commercial approval by the U.S. Food and Drug Administration (\"FDA\") of its new drug application for \"DSUVIA\" on or before February 15, 2019; and the remaining 50% of the award shall vest on the one-year anniversary of the date of such FDA approval, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 26,125 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 7, 2018, the reporting person was granted an option to purchase 52,250 shares of common stock. The option vests in two equal annual installments based on  Company's achievement of commercial approval by the U.S. Food and Drug Administration (\"FDA\") of its new drug application for \"DSUVIA\" on or before February 15, 2019; and the remaining 50% of the award shall vest on the one-year anniversary of the date of such FDA approval, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 26,125 shares."}],"balance_after":21125,"derivative":{"exercise_price":2.225,"exercise_date":"2018-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-057255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118057255/doc4.xml","form_type":"4"}},{"id":3774058,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T22:29:07.000Z","date":"2018-11-02","kind":"grant","acquired":true,"shares":26125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2018, the reporting person was granted an option to purchase 52,250 shares of common stock. The option vests in two equal annual installments based on  Company's achievement of commercial approval by the U.S. Food and Drug Administration (\"FDA\") of its new drug application for \"DSUVIA\" on or before February 15, 2019; and the remaining 50% of the award shall vest on the one-year anniversary of the date of such FDA approval, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 26,125 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 7, 2018, the reporting person was granted an option to purchase 52,250 shares of common stock. The option vests in two equal annual installments based on  Company's achievement of commercial approval by the U.S. Food and Drug Administration (\"FDA\") of its new drug application for \"DSUVIA\" on or before February 15, 2019; and the remaining 50% of the award shall vest on the one-year anniversary of the date of such FDA approval, in all cases subject to continuous service to the Company. The performance criteria for commercial approval by the FDA for DSUVIA was met on November 2, 2018, resulting in vesting of the option as to 26,125 shares."}],"balance_after":26125,"derivative":{"exercise_price":2.225,"exercise_date":"2018-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":26125},"source":{"system":"sec-edgar","filing":"0001209191-18-057255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118057255/doc4.xml","form_type":"4"}},{"id":3774057,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-11-05T22:29:07.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":5,"value":25000.0,"ownership":{"direct":false,"nature":"By the Hamel Revocable Living Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan."}],"balance_after":29795,"source":{"system":"sec-edgar","filing":"0001209191-18-057255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118057255/doc4.xml","form_type":"4"}},{"id":3774056,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-11-05T22:29:07.000Z","date":"2018-11-02","kind":"grant","acquired":true,"shares":5000,"price":2.225,"value":11125.0,"ownership":{"direct":false,"nature":"By the Hamel Revocable Living Trust"},"balance_after":34795,"source":{"system":"sec-edgar","filing":"0001209191-18-057255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118057255/doc4.xml","form_type":"4"}},{"id":3789787,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-10-16T20:30:52.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":5216,"price":5,"value":26080.0,"ownership":{"direct":false,"nature":"By the Hamel Revocable Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan."}],"balance_after":29795,"source":{"system":"sec-edgar","filing":"0001209191-18-055127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118055127/doc4.xml","form_type":"4"}},{"id":3807233,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-09-26T21:54:20.000Z","date":"2018-09-24","kind":"sale","acquired":false,"shares":6953,"price":4.5,"value":31288.5,"ownership":{"direct":false,"nature":"By the Hamel Revocable Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan."}],"balance_after":35011,"source":{"system":"sec-edgar","filing":"0001209191-18-052334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118052334/doc4.xml","form_type":"4"}},{"id":3825308,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-09-05T10:06:08.000Z","date":"2018-08-31","kind":"grant","acquired":true,"shares":6876,"price":1.49,"value":10245.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Company's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Non-reportable acquisition of 1,116 shares of common stock through the Company's Employee Stock Purchase Plan."}],"balance_after":24371,"source":{"system":"sec-edgar","filing":"0000899243-18-023787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000089924318023787/doc4.xml","form_type":"4"}},{"id":4088088,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-27T00:29:19.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Issued pursuant to the 2011 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months."}],"balance_after":95000,"derivative":{"exercise_price":2,"exercise_date":"2019-01-22","expiration_date":"2028-01-21","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001437749-18-001229","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774918001229/rdgdoc.xml","form_type":"4"}},{"id":4194277,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-10-03T20:37:59.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":10161,"price":5.29,"value":53751.69,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Shares were sold at prices ranging from $5.10 to $5.50.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Shares are held in the Hamel Revocable Living Trust."}],"balance_after":41964,"source":{"system":"sec-edgar","filing":"0001437749-17-016704","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917016704/rdgdoc.xml","form_type":"4"}},{"id":4200867,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-09-27T20:54:52.000Z","date":"2017-09-25","kind":"sale","acquired":false,"shares":13827,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Shares were sold in a range from $3.50-$4.50"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"52,125 of the Shares are held in the Hamel Revocable Living Trust"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"52,125 of the Shares are held in the Hamel Revocable Living Trust"}],"balance_after":68504,"source":{"system":"sec-edgar","filing":"0001437749-17-016405","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917016405/rdgdoc.xml","form_type":"4"}},{"id":4354393,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-11T21:29:56.000Z","date":"2017-04-10","kind":"disposition_to_issuer","acquired":false,"shares":9122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months."}],"balance_after":0,"derivative":{"exercise_price":1.2,"expiration_date":"2017-12-05","underlying":"Common Stock","underlying_shares":9122},"source":{"system":"sec-edgar","filing":"0001437749-17-006460","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917006460/rdgdoc.xml","form_type":"4"}},{"id":4354392,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-04-11T21:29:56.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":6879,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan."}],"balance_after":80354,"source":{"system":"sec-edgar","filing":"0001437749-17-006460","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917006460/rdgdoc.xml","form_type":"4"}},{"id":4354391,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-04-11T21:29:56.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":9122,"price":1.2,"value":10946.4,"ownership":{"direct":true},"balance_after":73475,"source":{"system":"sec-edgar","filing":"0001437749-17-006460","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917006460/rdgdoc.xml","form_type":"4"}},{"id":4459518,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":151701,"kind":"person","name":"Hamel Lawrence G","position":1,"cik":"0001511368","reported_name":"Hamel Lawrence G","relationship":{"officer":true,"officer_title":"Chief Development Officer"}}],"security":"Common Stock (Right to Buy)","published_at":"2017-02-10T02:03:29.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":79500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Issued pursuant to the 2011 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% Acceleration upon Change of Control."}],"balance_after":79500,"derivative":{"exercise_price":3,"exercise_date":"2018-02-07","expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":79500},"source":{"system":"sec-edgar","filing":"0001437749-17-002067","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917002067/rdgdoc.xml","form_type":"4"}}]}